A Study of PTX-9908 Injection for Non-resectable HCC With TACE
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Carcinoma, Hepatocellular
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Phase I: Singe-arm, open-labeled Phase II: Randomized, placebo-controlledMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: For Phase II only.Primary Purpose: Treatment
Participation Requirements
- Age
- Between 20 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03812874
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Chien-Hung Chien-Hung, MD, PhD National Taiwan University Hospital